Author: Michael Foster, Contrarian Outlook

Some major—and almost totally ignored—news from Washington, D.C., is about to upend the biotech world, turning America into “the world’s pharmacy” in short order—and giving us a chance to buy a solid 6.8% dividend for just 91 cents on the dollar.

Buy shares, as its current discount to NAV looks headed into premium territory.

It’s the go-to covered call fund.

Whether you own a Treasury or the typical dividend stock these days, you’re still losing money after inflation. But there’s a solution hiding in plain sight…

One of the market’s smartest contrarian players just made a shocking move — and we dividend investors need to pay attention.